Cargando…
A novel strategy for precise prognosis management and treatment option in colon adenocarcinoma with TP53 mutations
BACKGROUND: TP53 is one of the most frequent mutated genes in colon cancer. Although colon cancer with TP53 mutations has a high risk of metastasis and worse prognosis generally, it showed high heterogeneity clinically. METHODS: A total of 1,412 colon adenocarcinoma (COAD) samples were obtained from...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947352/ https://www.ncbi.nlm.nih.gov/pubmed/36843983 http://dx.doi.org/10.3389/fsurg.2023.1079129 |